Board of Advisors
Board of Advisors
Devana Solutions is proud to draw upon the leadership and varied experiences of our advisors. Our board consists of well-respected leaders in the clinical trial, software, and pharmaceutical industries. They help provide us with key vision and market insights, which we use to inform our strategic direction.
Reid Conrad
Board Member, CData Software
Reid is a successful entrepreneur with over 33 years of experience in the enterprise software & technology industry. Reid manages Commerciality, which provides strategy, corporate and business development advisory services to high growth companies. Reid's focus is in the field of IoT, big data, business intelligence & machine learning solutions in manufacturing, life sciences, industrial & enterprise sectors. Reid has coached & advised 100's of entrepreneurial companies in the technology sectors & life sciences sectors.
Tom Wollman
Senior Vice President, Syneos Health
As a C-Level leader experienced in regulated, global, multi-cultural environments, Tom combines financial acumen, leadership skills, and a keen understanding of business levers to pull to bring new energy to companies. Applying calculated decision-making and measured follow-up, Tom garners stakeholder loyalty and devises win-win client solutions to dramatically increase enterprise value, focusing on key priorities, improving business margins, and devising reasoned M&A strategy. With a proven record of growing companies from 150 people to 1900 and increasing revenue by more than $300 million, Tom truly enjoys the process of driving significant business growth.
Craig Koch
Executive Vice President, Velocity Clinical Research
Craig joined Velocity Clinical Research in 2019 as the Vice President of Business Development. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Craig’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics. Craig believes that the value patients bring to developing new medicines needs to be celebrated. New medicines are not possible without clinical trial volunteers, yet too few are aware of opportunities or how they can be involved. Prior to joining Velocity and the Devana Solutions Board of Advisors, Craig served a variety of leadership roles in scientific, business management, and process improvement across contract research organizations, clinical sites, and site networks.
Learn more about Devana Solutions: